210 related articles for article (PubMed ID: 26603173)
1. Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study.
Nguipdop-Djomo P; Heldal E; Rodrigues LC; Abubakar I; Mangtani P
Lancet Infect Dis; 2016 Feb; 16(2):219-26. PubMed ID: 26603173
[TBL] [Abstract][Full Text] [Related]
2. Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.
Mangtani P; Nguipdop-Djomo P; Keogh RH; Trinder L; Smith PG; Fine PE; Sterne J; Abubakar I; Vynnycky E; Watson J; Elliman D; Lipman M; Rodrigues LC
Health Technol Assess; 2017 Jul; 21(39):1-54. PubMed ID: 28738015
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.
Pereira SM; Barreto ML; Pilger D; Cruz AA; Sant'Anna C; Hijjar MA; Ichihara MY; Santos AC; Genser B; Rodrigues LC
Lancet Infect Dis; 2012 Apr; 12(4):300-6. PubMed ID: 22071248
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.
Abubakar I; Pimpin L; Ariti C; Beynon R; Mangtani P; Sterne JA; Fine PE; Smith PG; Lipman M; Elliman D; Watson JM; Drumright LN; Whiting PF; Vynnycky E; Rodrigues LC
Health Technol Assess; 2013 Sep; 17(37):1-372, v-vi. PubMed ID: 24021245
[TBL] [Abstract][Full Text] [Related]
5. The Long-term Effect of Bacille Calmette-Guérin Vaccination on Tuberculin Skin Testing: A 55-Year Follow-Up Study.
Mancuso JD; Mody RM; Olsen CH; Harrison LH; Santosham M; Aronson NE
Chest; 2017 Aug; 152(2):282-294. PubMed ID: 28087302
[TBL] [Abstract][Full Text] [Related]
6. BCG vaccination: a long-lasting protection against tuberculosis?
Hernández-Garduño E
Lancet Infect Dis; 2016 Apr; 16(4):408. PubMed ID: 27036343
[No Abstract] [Full Text] [Related]
7. BCG vaccination: a long-lasting protection against tuberculosis?--Authors' reply.
Nguipdop-Djomo P; Heldal E; Rodrigues LC; Abubakar I; Mangtani P
Lancet Infect Dis; 2016 Apr; 16(4):408-9. PubMed ID: 27036342
[No Abstract] [Full Text] [Related]
8. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis.
Martinez L; Cords O; Liu Q; Acuna-Villaorduna C; Bonnet M; Fox GJ; Carvalho ACC; Chan PC; Croda J; Hill PC; Lopez-Varela E; Donkor S; Fielding K; Graham SM; Espinal MA; Kampmann B; Reingold A; Huerga H; Villalba JA; Grandjean L; Sotgiu G; Egere U; Singh S; Zhu L; Lienhardt C; Denholm JT; Seddon JA; Whalen CC; García-Basteiro AL; Triasih R; Chen C; Singh J; Huang LM; Sharma S; Hannoun D; Del Corral H; Mandalakas AM; Malone LL; Ling DL; Kritski A; Stein CM; Vashishtha R; Boulahbal F; Fang CT; Boom WH; Netto EM; Lemos AC; Hesseling AC; Kay A; Jones-López EC; Horsburgh CR; Lange C; Andrews JR
Lancet Glob Health; 2022 Sep; 10(9):e1307-e1316. PubMed ID: 35961354
[TBL] [Abstract][Full Text] [Related]
9. Risk factors associated with latent tuberculosis infection in Mexican American children.
Young J; O'Connor ME
Pediatrics; 2005 Jun; 115(6):e647-53. PubMed ID: 15930191
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
[TBL] [Abstract][Full Text] [Related]
11. The duration of protection of school-aged BCG vaccination in England: a population-based case-control study.
Mangtani P; Nguipdop-Djomo P; Keogh RH; Sterne JAC; Abubakar I; Smith PG; Fine PEM; Vynnycky E; Watson JM; Elliman D; Lipman M; Rodrigues LC
Int J Epidemiol; 2018 Feb; 47(1):193-201. PubMed ID: 29025083
[TBL] [Abstract][Full Text] [Related]
12. The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection.
Seddon JA; Paton J; Nademi Z; Keane D; Williams B; Williams A; Welch SB; Liebeschutz S; Riddell A; Bernatoniene J; Patel S; Martinez-Alier N; McMaster P; Kampmann B
Thorax; 2016 Oct; 71(10):932-9. PubMed ID: 27335104
[TBL] [Abstract][Full Text] [Related]
13. The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi.
Glynn JR; Dube A; Fielding K; Crampin AC; ; Kanjala C; Fine PEM
Lancet Infect Dis; 2021 Nov; 21(11):1590-1597. PubMed ID: 34237262
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of tuberculin reactivity in different age groups with and without BCG vaccination].
Yildirim C; Küçük AI; Ongüt G; Oğünç D; Colak D; Mutlu G
Mikrobiyol Bul; 2009 Jan; 43(1):27-35. PubMed ID: 19334377
[TBL] [Abstract][Full Text] [Related]
15. BCG vaccination protects against infection with Mycobacterium tuberculosis ascertained by tuberculin skin testing.
Pelzer PT; Mutayoba B; Cobelens FGJ
J Infect; 2018 Oct; 77(4):335-340. PubMed ID: 29778630
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong.
Leung CC; Tam CM; Chan SL; Chan-Yeung M; Chan CK; Chang KC
Int J Tuberc Lung Dis; 2001 Aug; 5(8):717-23. PubMed ID: 11495262
[TBL] [Abstract][Full Text] [Related]
17. Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau.
Roth A; Jensen H; Garly ML; Djana Q; Martins CL; Sodemann M; Rodrigues A; Aaby P
Pediatr Infect Dis J; 2004 Jun; 23(6):544-50. PubMed ID: 15194836
[TBL] [Abstract][Full Text] [Related]
18. Influence of bacille Calmette-Guérin vaccination on size of tuberculin skin test reaction: to what size?
Tissot F; Zanetti G; Francioli P; Zellweger JP; Zysset F
Clin Infect Dis; 2005 Jan; 40(2):211-7. PubMed ID: 15655737
[TBL] [Abstract][Full Text] [Related]
19. BCG vaccination and multiple sclerosis risk: A Norwegian cohort study.
Nakken O; Aarseth JH; Wergeland S; Stigum H; Meyer HE; Holmøy T
Mult Scler; 2024 May; 30(6):646-653. PubMed ID: 38414125
[TBL] [Abstract][Full Text] [Related]
20. Tuberculin status, socioeconomic differences and differences in all-cause mortality: experience from Norwegian cohorts born 1910-49.
Liestøl K; Tretli S; Tverdal A; Maehlen J
Int J Epidemiol; 2009 Apr; 38(2):427-34. PubMed ID: 19339259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
